GlassScriptPhysician profile
Kyoko Arata
NPI 1790234482
$6,598.48
in general payments reported to CMS, 2019-2025
37 companies · $913 in 2025
The $913 reported for 2025 was more than what 84% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,060 · 2022: $1,937 · 2023: $1,544 · 2024: $1,144 · 2025: $913.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,589 · Education: $11.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,589.46 |
| Education | $11.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $852.76 | 2021-2025 | Prolia, Krystexxa, Evenity |
| Astrazeneca Pharmaceuticals LP | $831.96 | 2021-2025 | Farxiga, Breztri, Lokelma |
| Novo Nordisk INC | $633.01 | 2021-2024 | Wegovy, Rybelsus, Ozempic |
| Gilead Sciences, INC. | $622.99 | 2021-2025 | Vemlidy, Biktarvy |
| Bayer Healthcare Pharmaceuticals INC. | $581.76 | 2021-2023 | |
| Lilly USA, LLC | $497.28 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Kyowa Kirin, INC. | $235.23 | 2023-2024 | Crysvita |
| Biohaven Pharmaceutical Holding Company LTD. | $228.95 | 2022 | |
| Glaxosmithkline, LLC. | $167.54 | 2022-2024 | Trelegy Ellipta |
| Abbott Laboratories | $156.30 | 2024 | Freestyle Libre 3 |
| Idorsia Pharmaceuticals US INC | $154.12 | 2023 | Quviviq |
| Merck Sharp & Dohme LLC | $148.34 | 2021-2023 | Steglatro, Belsomra, Steglujan |
| Amarin Pharma, INC. | $139.20 | 2021-2022 | |
| Sk Life Science, INC. | $124.10 | 2024 | Xcopri |
| Otsuka America Pharmaceutical, INC. | $122.79 | 2025 | Rexulti |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyoko Arata listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.